It could become the first publicly listed company focused on AI-driven nanodelivery.
Written by IPO Zaozhidao
Published on
21 Apr 2026
7 mins read
On April 19, Metis TechBio (stylized as “METiS TechBio”) announced that it had cleared its listing hearing at Hong Kong Exchanges and Clearing (HKEX), a key step toward a Hong Kong IPO.
Hong Kong-listed AI-driven drug delivery innovation company Metis TechBio Co Ltd said on Tuesday it had granted Boulevard Bio, an…
AI-powered drug developer Metis TechBio leads group that includes developers of autonomous driving technology and industrial…
Its optical computing solutions could address key bottlenecks in AI systems.
MetaX Integrated Circuits plans a Hong Kong secondary listing after its Shanghai IPO saw shares surge 693% on debut. The GPU…
City emerges as a price-discovery hub, with mainland AI firms reversing a decades-old dual-listing order to secure global…
Biren’s strong start will likely augur well for two other AI-related stocks—MiniMax and Zhipu—that are set to list in HK next…
